Evidence map›Paper›PMID 32351147›Full record

ArticleThe Journal of international medical research2020

Progressive hemifacial atrophy with characteristic ocular manifestations in a Chinese patient with a

Jinghua Liu, Ying Liu, Liming Wang, Xiaohan Zhang, Peng Hao, Xuan Li

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of international medical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jinghua LiuTianjin Medical University, Tianjin, China.
Ying LiuSouthwest Medical University, Luzhou, China.
Liming WangTianjin Eye Hospital, Tianjin Eye Institute, Tianjin Key Laboratory of Ophthalmology and Visual Science, Clinical College of Ophthalmology, Tianjin Medical University, Tianjin, China.
Xiaohan ZhangTianjin Medical University, Tianjin, China.
Peng HaoTianjin Eye Hospital, Tianjin Eye Institute, Tianjin Key Laboratory of Ophthalmology and Visual Science, Clinical College of Ophthalmology, Tianjin Medical University, Tianjin, China.
Xuan LiTianjin Medical University, Tianjin, China.ORCID https://orcid.org/0000-0003-1052-4222
Nankai University · CNTianjin Medical University Eye Hospital · CNSouthwest Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Progressive hemifacial atrophy (PHA) is mainly characterized by asymmetrical atrophy of craniofacial tissue; however, 10% to 30% of patients with PHA exhibit ocular manifestations. Here, we describe abnormal ocular findings in a Chinese patient with PHA. The patient was a 29-year-old Chinese man. Characteristic ocular findings in his affected eye included keratic precipitate, corneal endothelial degeneration, fundus tessellation, pupillary dilation, direct light reflex loss, and visual evoked potential alteration. Whole exosome sequencing revealed that the patient harbored a mutation in the

Indexed as

MutationPhenotypeAdultBiomarkersDisease ProgressionDNA Mutational AnalysisExome SequencingEye DiseasesEye ProteinsFacial HemiatrophyFluorescein AngiographyGenetic Association StudiesGenetic Predisposition to DiseaseHumansMaleMembrane ProteinsBiomarkersCRB1 protein, humanEye ProteinsMembrane ProteinsNerve Tissue Proteinscorneal endothelial degenerationCRB1 mutationexosome sequencingfundus tessellationGene mutationkeratic precipitateprogressive hemifacial atrophypupillary dilationvisual evoked potential

Identifiers

PMID32351147
PMCPMC7221477
OpenAlexW3021603425

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.